Regulatory Data Protection Promotes Biopharmaceutical Innovation and Patient Access

The biopharmaceutical industry uses its scientific and technical expertise to research, develop, manufacture and distribute safe and effective treatments and vaccines to patients around the world. The intellectual property (IP) system enables this investment and supports competition. Regulatory data protection (RDP) is a critical element of effective IP systems and is a critical component of international IP rules. 

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.